Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kingo Chida is active.

Publication


Featured researches published by Kingo Chida.


European Respiratory Journal | 2006

Interstitial lung diseases associated with amyopathic dermatomyositis

Takafumi Suda; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Tateaki Naito; Dai Hashimoto; Jun Sato; Mikio Toyoshima; Hideo Hashizume; Kingo Chida

The aim of the present study was to clarify the clinical characteristics and prognosis of patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM). The study consisted of 14 consecutive patients with ILD-ADM. Patients were classified into two categories, acute/subacute and chronic forms, according to the clinical presentation of ILD. The clinical features, responsiveness to therapy, and prognosis between the two forms were compared. Nine ILD-ADM patients were categorised as the acute/subacute form, and five as the chronic form. Arterial oxygen tension was significantly lower in the acute/subacute ILD than chronic ILD patients. On high-resolution computed tomography, ground-glass opacities were frequently found in the two forms, but consolidation was more common in acute/subacute ILD than chronic ILD. Bronchoalveolar lavage analysis showed higher numbers of total cells and lymphocytes in acute/subacute ILD than chronic ILD. Histologically, the most common finding was nonspecific interstitial pneumonia in the two forms, while diffuse alveolar damage was only found in acute/subacute ILD. Acute/subacute ILD was generally resistant to therapy, while chronic ILD responded well. Notably, the mortality of acute/subacute ILD was much higher than that of chronic ILD (67 versus 0%, respectively). In conclusion, interstitial lung disease associated with amyopathic dermatomyositis includes two different forms, the acute/subacute and chronic forms, with distinct prognoses.


Biochemical and Biophysical Research Communications | 2003

High expression of Cks1 in human non-small cell lung carcinomas

Naoki Inui; Kyoko Kitagawa; Seiichi Miwa; Takayuki Hattori; Kingo Chida; Hirotoshi Nakamura; Masatoshi Kitagawa

Enhanced degradation of cyclin-dependent kinase (CDK) inhibitor p27(Kip1) is known to be a powerful prognostic marker in many types of human cancers. Human CDK subunit 1 (Cks1) and S-phase kinase associated protein 2 (Skp2) are components of the SCF(Skp2) complex, which acts as a ubiquitin ligase for p27(Kip1). There are no reports about the involvement of Cks1 in the pathogenesis of human cancer. Here we show high expression of Cks1 in non-small cell lung cancers (NSCLCs) using Western blotting and quantitative real-time RT-PCR. The Skp2 mRNA expression level was high in squamous cell carcinomas and was inversely related with the p27(Kip1) protein level in individual clinical samples. In contrast, Cks1 mRNA expression had no such relationship with p27(Kip1), although Cks1 mRNA was significantly elevated in adenocarcinomas. These results suggest that high expression of Skp2 and Cks1 may be involved in the pathogenesis of NSCLCs via different mechanisms.


Chest | 2008

Alterations in Smoking Habits Are Associated With Acute Eosinophilic Pneumonia

Hiroshi Uchiyama; Takafumi Suda; Yutaro Nakamura; Masahiro Shirai; Hitoshi Gemma; Toshihiro Shirai; Mikio Toyoshima; Shiro Imokawa; Kazumasa Yasuda; Masaaki Ida; Yutaka Nakano; Naoki Inui; Jun Sato; Hiroshi Hayakawa; Kingo Chida

BACKGROUND Acute eosinophilic pneumonia (AEP) is characterized by a febrile illness, diffuse pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, but several studies have proposed a relationship between cigarette smoking and AEP. However, most studies showing this possibility are single-case reports, and cigarette smoke has not been fully validated as a causative agent of AEP in a large series of patients. The present study was conducted to clarify the etiologic role of cigarette smoking in AEP, with special reference to alterations in smoking habits. METHODS We took a detailed history of smoking habits before AEP onset in 33 patients with AEP, and performed a cigarette smoke provocation test. RESULTS Of our AEP patients, all but one (97%) were current smokers. Interestingly, 21 of these were new-onset smokers, and 2 had restarted smoking after a 1- to 2-year cessation of smoking. The duration between starting smoking and AEP onset was within 1 month (0.67 +/- 0.53 months). Additionally, six of the remaining smokers had increased the quantity of cigarettes smoked daily, fourfold to fivefold, mostly within the month before AEP onset (0.81 +/- 0.58 months). Only three smokers had not changed their smoking habits before AEP onset. Cigarette smoke provocation tests revealed positive results in all nine patients tested. CONCLUSION These data suggest that recent alterations in smoking habits, not only beginning to smoke, but also restarting to smoke and increasing daily smoking doses, are associated with the development of AEP.


The Journal of Allergy and Clinical Immunology | 2003

Elevated complement C3a in plasma from patients with severe acute asthma.

Yutaka Nakano; Satoru Morita; Akira Kawamoto; Takahumi Suda; Kingo Chida; Hirotoshi Nakamura

BACKGROUND Complement component C3a, an anaphylatoxin, provokes acute inflammatory responses, including smooth muscle contraction, mucus hypersecretion, increase in vascular permeability, and recruitment of inflammatory cells. Thus C3a may be related to airway inflammation and bronchoconstriction in acute asthma exacerbation. OBJECTIVE We sought to determine whether plasma C3a is elevated in patients presenting for emergency treatment of acute asthma exacerbations and to correlate C3a concentrations with response to therapy. METHODS Plasma C3a and serum eosinophil cationic protein were measured in 52 patients with acute asthma with peak expiratory flow of < or =50% the predicted value. Control subjects were 42 patients with stable chronic asthma. Patients with severe acute asthma were classified into 2 groups (admitted and discharged), according to how effective inhaled bronchodilators and systemic corticosteroids were in the first 2 hours of treatment. RESULTS Concentrations of C3a in plasma from subjects in the admitted group (median, 256 ng/mL; range, 94 to 454) were significantly higher than those in the discharged group (197 ng/mL; 72 to 300) or those in patients with stable chronic asthma (166 ng/mL; 89 to 254; P <.0001). Elevated plasma C3a concentrations in admitted asthmatic patients decreased significantly by 7 days after admission (P =.0005). No significant difference was evident in serum eosinophil cationic protein concentration between the admitted group (33.1 microg/L; 6.3 to 143) and the discharged group (32.7 microg/L; 14.6 to 160; P =.99). CONCLUSIONS Concentrations of C3a, which can induce airway inflammation and bronchoconstriction, were associated with differences in response to emergency treatment of severe asthma exacerbation.


Respirology | 2008

Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia.

Noriyuki Enomoto; Takafumi Suda; Tomohiro Uto; Masato Kato; Yusuke Kaida; Yuichi Ozawa; Hiroo Miyazaki; Shigeki Kuroishi; Dai Hashimoto; Tateaki Naito; Tomoyuki Fujisawa; Takashi Matsui; Naoki Inui; Yutaro Nakamura; June Sato; Tomoaki Mizuguchi; Akihiko Kato; Kingo Chida

Background and objective:  Acute exacerbations of interstitial pneumonias (IP) can occasionally occur, and have an extremely poor prognosis. Recently, direct haemoperfusion with a polymyxin B immobilized fibre column (PMX‐DHP) was shown to have a beneficial effect in acute exacerbations of IPF. However, little is known about the efficacy of PMX‐DHP in acute exacerbations of other IP. This study investigated the effectiveness and safety of PMX‐DHP in acute exacerbations of IP.


European Respiratory Journal | 2008

Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings

Shigeki Kuroishi; Yutaro Nakamura; Hiroshi Hayakawa; Masahiro Shirai; Yasukatsu Nakano; Kazumasa Yasuda; Takafumi Suda; Hirotoshi Nakamura; Kingo Chida

To evaluate the prognostic implications of computed tomography (CT) findings in assessing responses to treatment in Mycobacterium avium complex (MAC) pulmonary disease without underlying lung disease, high-resolution (HR)CT findings were correlated based on the results of sputum conversion after anti-MAC therapy. A total of 59 patients underwent HRCT before treatment and the therapeutic efficacy was evaluated by the results of sputum conversion. Atelectasis, cavities and pleural thickening on HRCT were significantly more frequent and extensive among patients in the sputum nonconverted group than among those in the converted group. Furthermore, bronchiectasis was also significantly more extensive among patients in the nonconverted group, even though there was no significant difference in frequency between these two groups. These results suggest that high-resolution computed tomography findings are good predictors of response to treatment in Mycobacterium avium complex pulmonary disease.


Journal of the American Geriatrics Society | 2006

A Validation and Potential Modification of the Pneumonia Severity Index in Elderly Patients with Community-Acquired Pneumonia

Tateaki Naito; Takafumi Suda; Kazumasa Yasuda; Takashi Yamada; Akihito Todate; Tomoyoshi Tsuchiya; Jun Sato; Kingo Chida; Hirotoshi Nakamura

OBJECTIVES: To evaluate the discriminatory power of the Pneumonia Severity Index (PSI) in elderly patients with community‐acquired pneumonia (CAP) and to improve its performance.


Clinical & Experimental Allergy | 2003

Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness.

Toshihiro Shirai; K. Reshad; A. Yoshitomi; Kingo Chida; Hirotoshi Nakamura; Masami Taniguchi

Background The relationships between immunological reactivity and bronchial responsiveness to allergen and non‐specific bronchial responsiveness are unclear in occupational asthma caused by low molecular weight substances.


Clinical & Experimental Allergy | 2003

Th1/Th2 profile in peripheral blood in atopic cough and atopic asthma

Toshihiro Shirai; Kenichiro Suzuki; Naoki Inui; Takafumi Suda; Kingo Chida; Hirotoshi Nakamura

Background Eosinophilic tracheobronchitis with cough hypersensitivity, abbreviated as atopic cough, is an important cause of chronic cough. The reason for the absence of airway hyper‐responsiveness is unknown, differing from asthma, a Th2 cytokine‐mediated disorder.


Respirology | 2002

Clinicopathological features of chronic hypersensitivity pneumonitis

Hiroshi Hayakawa; Masahiro Shirai; Atsuhiko Sato; Yasuyuki Yoshizawa; Akihito Todate; Shiro Imokawa; Takafumi Suda; Kingo Chida; Ryoji Tamura; Kyousuke Ishihara; Shigeki Saiki; Masayuki Ando

Objective: Only limited information exists concerning the clinical and pathological features of chronic hypersensitivity pneumonitis (HP) in Japan and elsewhere. We present data on clinicopathological features of chronic HP obtained through a Japanese nationwide survey.

Collaboration


Dive into the Kingo Chida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Sato

Hamamatsu University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge